Rep. Alexandria Ocasio-Cortez (D-New York) responded to news about the Biden administration’s endorsement of plans to waive the patents for coronavirus vaccines by tweeting out another proposal: Do the same thing for insulin.
Officials in the Biden administration expressed support Wednesday for waiving COVID-19 vaccine patents in order to help other countries around the world (particularly those that might not be able to buy doses in bulk at higher costs) develop their own vaccines, which could help control the spread of the virus and prevent the occurrence of new variants.
“This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures,” said U.S. Trade Representative Katherine Tai in a statement. “The administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines.”
Within hours of the announcement, stock shares for companies that have produced vaccines for the virus went down. Ocasio-Cortez shared an image showing the stock drops, and tweeted a message of her own: “Let’s do insulin next.”
Let’s do insulin next https://t.co/VWhwyxbzd9
— Alexandria Ocasio-Cortez (@AOC) May 5, 2021
Ocasio-Cortez also retweeted a message from Eric Feigl-Ding, an epidemiologist and health economist, who endorsed the idea of making insulin more affordable through ending patents on the drug.
“There is no reason for insulin to cost $21 in Canada for a 10 ml bottle, while it costs a mortgage payment in the US,” Feigl-Ding added.
Currently, newer versions of insulin retail for around $175 to $300 per vial, according to a recent report from Forbes. Most diabetes patients require around two to three vials per month, with some patients requiring more depending on their health needs.
For individuals with lower incomes and those who pay out of pocket, the price of insulin is incredibly burdensome, and often results in patients making difficult choices that can be harmful to their health, including rationing their dosages in order to make their supplies of the drug last longer.
A 2019 study found that one in four diabetes patients “reported cost-related insulin underuse” that resulted in “poor glycemic control.” One-third of those who had difficulties affording the medicine did not discuss the issue with their doctors.
Medical experts are well aware of what’s driven up insulin costs over the years. While the original patent for the drug sold for just $1 almost 100 years ago, drug companies have made incremental improvements on the drug since the 1920s, and current law allows them to keep patents on insulin as it changes — and prevent a generic version from becoming available.
Companies do not continue to manufacture older versions of the drug, as their use is deemed obsolete by doctors who prefer to use the new and more effective versions that are available.
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.